非小细胞肺癌endocan?FLK-1的表达与血管生成相关性研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


The Expression of endocan and FLK-1 and their correlations with angiogenesis in non small cell lung cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:研究内皮细胞特异分子-1(endothelial cell specific-1,endocan)-血管内皮细胞生长因子受体(KDR/FLK-1)在非小细胞肺癌(NSCLC)中的表达及其临床意义,同时探讨endocan-FLK-1与非小细胞肺癌血管生成的相关性-方法:应用免疫荧光技术检测60例手术切除的肺癌组织-21例癌旁肺组织(距癌组织5 cm以上)中的endocan表达水平;免疫组化SP法检测FLK-1表达, 并计数微血管密度(MVD)-结果:endocan-FLK-1的表达在NSCLC组织中明显高于癌旁组织(P均 < 0.05);endocan-FLK-1的表达与NSCLC的淋巴结转移-TNM分期正相关(P均 < 0.05),而与NSCLC的组织学分类无关(P均 > 0.05);在NSCLC中MVD-endocan-FLK-1阳性表达组明显高于二者阴性表达组(P均 < 0.05);endocan-FLK-1在NSCLC中的表达呈正相关(r = 0.888 9,P < 0.05)-结论:endocan-FLK-1在NSCLC组织的血管发生-进展等病理过程有重要作用-

    Abstract:

    Objective:To investigate the expression of endocan and FLK-1 in NSCLC, and to explore the correlation with angiogenesis and other clinical pathophysiological characteristics of NSCLC. Methods:The expression of endocan was detected by using immunofluorescence technique in 60 specimens of NSCLC and 21 specimens of adjacent non-cancerous tissues as control group. Immunohistochemical S-P method was performed to estimate the expression of FLK-1 and MVD. Results:The endocan-positive rate was 78.33%(47/60) in NSCLC group and 14.29%(3/21) in control group. The positive rate of FLK-1 was 71.67%(43/60)in NSCLC group and 19.05%(4/21) in control group. There was a significant difference between them(χ2 = 27.01,17.68; all P < 0.05). In stage Ⅰ+Ⅱ and Ⅲ+Ⅳ of NSCLC, the positive rates of endocan were 67.64%(23/34) and 92.30%(24/26) while the positive rates of FLK-1 were 58.82%(20/34) and 88.46%(23/26). The differences of endocan and FLK-1 expression between stageⅠ+Ⅱ and Ⅲ+Ⅳ were significant respectively(χ2=5.28, 6.37, all P < 0.05). In the group with lymph node metastasis and the group without lymph node metastasis, the positive rates of endocan were 84.78%(39/46) and 57.14%(8/14), the positive rates of FLK-1 were 80.43%(37/46) and 42.86%(6/14). The differences of endocan and FLK-1 expression between the two groups were also significant respectively(χ2 = 4.83,7.46,all P < 0.05). The MVDs in the endocan-positive group and the endocan-negative group were 25.16 ± 5.12 and 18.97 ± 3.28 respectively, the difference was significant(t = 4.52, P < 0.05). The MVDs in the FLK-1-positive group and the FLK-1-negative group were 24.65 ± 4.34 and 18.92 ± 3.35 respectively, the difference was also significant(t = 5.23,P < 0.05). There was positive correlation between the expressions of endocan and FLK-1 in NSCLC(r = 0.8889, P < 0.05). However, The positive rates of endocan were 77.42%(24/31) in adenocarcinoma, 80.00%(20/25) in squamous cell carcinoma and 75.00%(3/4) in large cell lung cancer. The positive rates of FLK-1 were 70.96%(22/31) in adenocarcinoma,72.00%(18/25) in squamous cell carcinoma and 75.00%(3/4) in large cell lung cancer. There was no significant difference among them(χ2=3.63,1.79, all P > 0.05). Conclusion:Endocan and FLK-1 might play very important roles in tumor angiogenesis in NSCLC.

    参考文献
    相似文献
    引证文献
引用本文

万锦平,黄建安,穆传勇,刘 皓,鲁常青.非小细胞肺癌endocan?FLK-1的表达与血管生成相关性研究[J].南京医科大学学报(自然科学版),2009,29(1):28-31

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2008-09-24
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期: